Study of CX1106 in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Condition:   Head and Neck Squamous Cell Carcinoma Intervention:   Drug: CX1106 Sponsors:   Beijing Konruns Pharmaceutical Co., Ltd.;   National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials